Pleomorphic adenoma surgery: Difference between revisions

Jump to navigation Jump to search
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Pleomorphic adenoma}}
{{Pleomorphic adenoma}}
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{M.N}}


==Overview==
==Overview==
Line 12: Line 12:
==Surgery==
==Surgery==
[[Surgery operation|Surgery]] is the mainstay of [[Treatment Planning|treatment]] for pleomorphic adenoma.There are two procedures:
[[Surgery operation|Surgery]] is the mainstay of [[Treatment Planning|treatment]] for pleomorphic adenoma.There are two procedures:
*[[Superficial]] [[parotidectomy]]([[Patey's operation]]).
*[[Superficial]] [[parotidectomy]]([[Patey's operation]])<ref name="KadletzGrasl2017">{{cite journal|last1=Kadletz|first1=Lorenz|last2=Grasl|first2=Stefan|last3=Grasl|first3=Matthäus C.|last4=Perisanidis|first4=Christos|last5=Erovic|first5=Boban M.|title=Extracapsular dissection versus superficial parotidectomy in benign parotid gland tumors: The Vienna Medical School experience|journal=Head & Neck|volume=39|issue=2|year=2017|pages=356–360|issn=10433074|doi=10.1002/hed.24598}}</ref>.
*Total [[parotidectomy]], is the more frequently performed procedure due to the [[incidence]] of recurrence being lower. <ref name="KadletzGrasl2017">{{cite journal|last1=Kadletz|first1=Lorenz|last2=Grasl|first2=Stefan|last3=Grasl|first3=Matthäus C.|last4=Perisanidis|first4=Christos|last5=Erovic|first5=Boban M.|title=Extracapsular dissection versus superficial parotidectomy in benign parotid gland tumors: The Vienna Medical School experience|journal=Head & Neck|volume=39|issue=2|year=2017|pages=356–360|issn=10433074|doi=10.1002/hed.24598}}</ref>
*Total [[parotidectomy]], is the more frequently performed procedure due to the [[incidence]] of recurrence being lower.
*Care should be taken in order to preserve the [[facial nerve]]. <ref name="KadletzGrasl2017">{{cite journal|last1=Kadletz|first1=Lorenz|last2=Grasl|first2=Stefan|last3=Grasl|first3=Matthäus C.|last4=Perisanidis|first4=Christos|last5=Erovic|first5=Boban M.|title=Extracapsular dissection versus superficial parotidectomy in benign parotid gland tumors: The Vienna Medical School experience|journal=Head & Neck|volume=39|issue=2|year=2017|pages=356–360|issn=10433074|doi=10.1002/hed.24598}}</ref>
*Care should be taken in order to preserve the [[facial nerve]]. <ref name="KadletzGrasl2017">{{cite journal|last1=Kadletz|first1=Lorenz|last2=Grasl|first2=Stefan|last3=Grasl|first3=Matthäus C.|last4=Perisanidis|first4=Christos|last5=Erovic|first5=Boban M.|title=Extracapsular dissection versus superficial parotidectomy in benign parotid gland tumors: The Vienna Medical School experience|journal=Head & Neck|volume=39|issue=2|year=2017|pages=356–360|issn=10433074|doi=10.1002/hed.24598}}</ref>
*The [[tumors]] of the [[submandibular glands]] are treated with [[excision]] while preserving the adjacent [[nerves]] including the [[mandibular branch]] of the [[Trigeminal nerves|trigeminal nerve]], the [[hypoglossal nerve]], and the [[lingual nerve]].
*The [[tumors]] of the [[submandibular glands]] are treated with [[excision]] while preserving the adjacent [[nerves]] including the [[mandibular branch]] of the [[Trigeminal nerves|trigeminal nerve]], the [[hypoglossal nerve]], and the [[lingual nerve]].
Line 23: Line 23:
**Myxoid subtype  
**Myxoid subtype  
**Presence of the satellite [[nodules]] and [[tumor]] extensions
**Presence of the satellite [[nodules]] and [[tumor]] extensions
*Adjuvant [[radiotherapy]] has been shown to be helpful in managing a recurrent pleomorphic adenoma in addition to [[Surgery operation|surgery]].<ref name="Mc LoughlinGillanders2018">{{cite journal|last1=Mc Loughlin|first1=Laura|last2=Gillanders|first2=Sarah Louise|last3=Smith|first3=Susan|last4=Young|first4=Orla|title=The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review|journal=European Archives of Oto-Rhino-Laryngology|year=2018|issn=0937-4477|doi=10.1007/s00405-018-5205-z}}</ref>
*[[Adjuvant]] [[radiotherapy]] has been shown to be helpful in managing a recurrent pleomorphic adenoma in addition to [[Surgery operation|surgery]].<ref name="Mc LoughlinGillanders2018">{{cite journal|last1=Mc Loughlin|first1=Laura|last2=Gillanders|first2=Sarah Louise|last3=Smith|first3=Susan|last4=Young|first4=Orla|title=The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review|journal=European Archives of Oto-Rhino-Laryngology|year=2018|issn=0937-4477|doi=10.1007/s00405-018-5205-z}}</ref>


==Contraindications==
==Contraindications==
Line 33: Line 33:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]
 
[[Category: Otolaryngology]]
[[Category: Medicine]]
[[Category: Oncology]]
[[Category: Surgery]]
[[Category: Up-To-Date]]

Latest revision as of 20:04, 28 January 2019

Pleomorphic adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pleomorphic adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pleomorphic adenoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pleomorphic adenoma surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pleomorphic adenoma surgery

CDC on Pleomorphic adenoma surgery

Pleomorphic adenoma surgery in the news

Blogs on Pleomorphic adenoma surgery

Directions to Hospitals Treating Pleomorphic adenoma

Risk calculators and risk factors for Pleomorphic adenoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]

Overview

Surgery is the mainstay of treatment for pleomorphic adenoma. There are two procedures superficial parotidectomy and total parotidectomy, the latter of which is the most commonly performed one due to its low incidence on recurrence of the tumor. The complications after surgery include facial nerve palsy, frey's syndrome, trismus, haematoma or haemorrhage and wound infection. Recurrence do occur in pleomorphic adenoma sometimes.

Indications

  • Surgical intervention is recommended for the management of pleomorphic adenoma.

Surgery

Surgery is the mainstay of treatment for pleomorphic adenoma.There are two procedures:

Contraindications

There aren't any well established contraindications for the surgery of pleomorphic adenoma.

References

  1. 1.0 1.1 Kadletz, Lorenz; Grasl, Stefan; Grasl, Matthäus C.; Perisanidis, Christos; Erovic, Boban M. (2017). "Extracapsular dissection versus superficial parotidectomy in benign parotid gland tumors: The Vienna Medical School experience". Head & Neck. 39 (2): 356–360. doi:10.1002/hed.24598. ISSN 1043-3074.
  2. Kiciński K, Mikaszewski B, Stankiewicz C (February 2016). "Risk factors for recurrence of pleomorphic adenoma". Otolaryngol Pol. 70 (3): 1–7. doi:10.5604/00306657.1193691. PMID 27386926.
  3. Mc Loughlin, Laura; Gillanders, Sarah Louise; Smith, Susan; Young, Orla (2018). "The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review". European Archives of Oto-Rhino-Laryngology. doi:10.1007/s00405-018-5205-z. ISSN 0937-4477.

Template:WH Template:WS